Disease severity and prior treatment usage in patients with atopic dermatitis initiating dupilumab: An update from the GLOBOSTAD observational study

被引：0
|
作者：
Ferrucci, S. M. [1 ]
Rossi, M. [2 ]
Fomina, D. S. [3 ,4 ]
Lapeere, H. [5 ]
Hung, C. Wen [6 ]
Tzellos, T. [7 ]
Fougerousse, A. C. [8 ,9 ]
Ardeleanu, M. [10 ]
Bosman, K. [11 ]
机构：
[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[2] Univ Brescia, Brescia, Italy
[3] City Clin Hosp NO 52, Moscow, Russia
[4] IM Sechenov First Moscow State Med Univ, Moscow, Russia
[5] Ghent Univ Hosp, Ghent, Belgium
[6] Chang Gung Mem Hosp, Taipei, Taiwan
[7] Arctic Univ Norway, Inst Clin Med, Tromso, Norway
[8] Mil Teaching Hosp Begin, St Mande, France
[9] ResoEczema, Paris, France
[10] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[11] Sanofi, Amsterdam, Netherlands
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000402
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [21] Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients
    Costedoat, Ingrid
    Wallaert, Martin
    Gaultier, Aurelie
    Vasseur, Robin
    Vanhaecke, Clelia
    Viguier, Manuelle
    Cordelette, Charles
    Denoyer, Alexandre
    le Bouedec, Marie-Christine Ferrier
    Coutu, Adrien
    Lamiaux, Marie
    Tran, Thi Ha Chau
    Lacour, Jean Philippe
    Elmaleh, Valerie
    Tetart, Florence
    Gueudry, Julie
    Tauber, Marie
    Giordano-Labadie, Francoise
    Cassagne, Myriam
    Nosbaum, Audrey
    Ouilhon, Coralie
    Jachiet, Marie
    Tadayoni, Ramin
    Dezoteux, Frederic
    Staumont-Salle, Delphine
    Bouleau, Julien
    Labalette, Pierre
    Doan, Serge
    Soria, Angele
    Mortemousque, Bruno
    Seneschal, Julien
    Barbarot, Sebastien
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (05) : 1056 - 1063
  • [22] MULTICENTRE PROSPECTIVE OBSERVATIONAL STUDY OF DUPILUMAB-INDUCED OCULAR EVENTS IN ATOPIC DERMATITIS PATIENTS
    Costedoat, Ingrid
    Wallaert, Martin
    Gaultier, Aurelie
    Vasseur, Robin
    Vanhaecke, Clelia
    Viguier, Manuelle
    Cordelette, Charles
    Denoyer, Alexandre
    le Bouedec, Marie-Christine Ferrier
    Coutu, Adrien
    Lamiaux, Marie
    Thi Ha Chau Tran
    Lacour, Jean-Philippe
    Elmaleh, Valerie
    Tetart, Florence
    Gueudry, Julie
    Tauber, Marie
    Giordano-Labadie, Francoise
    Cassagne, Myriam
    Nosbaum, Audrey
    Ouilhon, Coralie
    Jachiet, Marie
    Tadayoni, Ramin
    Dezoteux, Frederic
    Staumont-Salle, Delphine
    Bouleau, Julien
    Labalette, Pierre
    Doan, Serge
    Soria, Angele
    Mortemousque, Bruno
    Seneschal, Julien
    Barbarot, Sebastien
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 32 - 33
  • [23] Physician-assessed effectiveness and safety in adolescent and adult atopic dermatitis patients treated with dupilumab: real-world insights one year into the GLOBOSTAD multinational prospective observational study
    Ferrucci, Silvia M.
    Calzavara-Pinton, Piergiacomo
    Karlova, Iva
    Lapeere, Hilde
    Holzer, Gregor
    Al-Ahmad, Mona
    Chu, Chia-Yu
    Wu, Jiangming
    Ardeleanu, Marius
    Bosman, Kwinten
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [24] Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?
    Pistone, G.
    Tilotta, G.
    Gurreri, R.
    Castelli, E.
    Curiale, S.
    Bongiorno, M. R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (06) : E255 - E256
  • [25] THE PATHOGENESIS AND COURSE OF OCULAR SURFACE DISEASE DURING DUPILUMAB TREATMENT IN ATOPIC DERMATITIS PATIENTS
    Achten, Roselie
    van Luijk, Chantal
    van der Wal, Marlot
    Thijs, Judith
    van Wijk, Femke
    de Graaf, Marlies
    Bakker, Daphne S.
    de Boer, Joke
    de Bruin-Weller, Marjolein S.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 18 - 18
  • [26] Patient-reported outcomes and safety in adolescent and adult atopic dermatitis patients treated with dupilumab: real-world insights one year into the GLOBOSTAD multinational prospective observational study
    Murrell, Dedee F.
    Ferrucci, Silvia M.
    Foti, Caterina
    Perez-Garcia, Bibiana
    Lapeere, Hilde
    Calzavara-Pinton, Piergiacomo
    Fougerousse, Anne-Claire
    Wu, Jiangming
    Ardeleanu, Marius
    Bosman, Kwinten
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [27] An Open-Label Prospective Observational Study of Tralokinumab in Atopic Dermatitis Patients with Inadequate Response to Dupilumab
    Polaskey, Meredith Tyree
    Fakhraie, Sheiva
    Daftary, Karishma
    Chovatiya, Raj
    DERMATITIS, 2024,
  • [28] DISPARITY IN DISEASE SEVERITY AND TREATMENT UTILIZATION FOR ATOPIC DERMATITIS (AD) PATIENTS IN THE US
    Verma, V.
    Pullagurla, S. R.
    Bhargava, S.
    Dawar, V
    Brooks, L.
    Kumar, K.
    Nayyar, A.
    Paul, A.
    VALUE IN HEALTH, 2023, 26 (06) : S394 - S394
  • [29] Instrumental evaluation of skin barrier function and clinical outcomes during dupilumab treatment for atopic dermatitis: An observational study
    Cristaudo, Antonio
    Pigliacelli, Flavia
    Sperati, Francesca
    Orsini, Diego
    Cameli, Norma
    Morrone, Aldo
    Mariano, Maria
    SKIN RESEARCH AND TECHNOLOGY, 2021, 27 (05) : 810 - 813
  • [30] Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
    Patruno, Cataldo
    Fabbrocini, Gabriella
    Longo, Giuseppe
    Argenziano, Giuseppe
    Ferrucci, Silvia Mariel
    Stingeni, Luca
    Peris, Ketty
    Ortoncelli, Michela
    Offidani, Annamaria
    Amoruso, Giuseppe Fabrizio
    Talamonti, Marina
    Girolomoni, Giampiero
    Grieco, Teresa
    Iannone, Michela
    Nettis, Eustachio
    Foti, Caterina
    Rongioletti, Franco
    Corazza, Monica
    Veneri, Michele Delli
    Napolitano, Maddalena
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 581 - 586
12345